scorecardresearch
Thursday, March 28, 2024
TopicCovid vaccine

Topic: Covid vaccine

Govt could wait for Covid vaccine before declaring steps to revive demand, says CEA Subramanian

Speaking at a virtual seminar, Krishnamurthy Subramanian said uncertainty is hurting demand and pointed out that people are preferring to save than spend. 

An Oxford immunologist breaks down how the university’s vaccine works against Covid-19

Oxford University and AstraZeneca tested its Covid vaccine — ChAdOx1 nCoV-19 543 — on 543 healthy adults. The results are promising. But we may need yearly booster doses.

Now US accuses two Chinese hackers of stealing secrets, including Covid vaccine research

The US Justice Department accused China of 'providing a safe haven' for hackers and said it knew the identity of officials who aided them, but would not indict them right now.

Delhi’s Covid-19 infection fatality rate stands at 0.07%, show sero survey results

Large variation in infection rates found in 11 districts with Central Delhi registering the highest rate at 27.86%. 

Chances of Covid vaccine by this year is ‘very low’, says Boris Johnson’s medical adviser

The assessment came despite the Oxford vaccine effort showing promising results in early human testing and is a sign of ongoing uncertainty over the likelihood of quick success.

Immunotherapy could be safe for cancer patients with Covid, early data indicates

From nanoparticle vaccine to antibody cocktail for treatment, ThePrint brings you the latest research on the novel coronavirus.

Two shots of Covid vaccine may be better than one, but that makes it all very complicated

Early study of more than 1,000 participants receiving the Oxford vaccine achieved the strongest immune response in 10 who received two doses, says research published in The Lancet.

Why we should not hype the hope for the Oxford-AstraZeneca Covid vaccine

It's important to remember that at this early stage in the process, every piece of vaccine data is still just part of a thesis that needs confirmation.

T cells produced, mild side effects — decoding why Oxford’s vaccine offers new Covid hope

The results of the phase 1 trials for the Oxford vaccine are preliminary, but indicate a likely chance of expedited vaccine delivery.

Great news on Covid vaccine as Oxford trial shows dual immune action against coronavirus

Oxford vaccine is at the front of 160 coronavirus vaccines in various stages of development. AstraZeneca may begin delivering doses to UK as early as September.

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.